The effect of quinolones on the intracellular killing of Staphylococcus aureus in neutrophil granulocytes

The Journal of Antimicrobial Chemotherapy
S L NielsenP L Andersen

Abstract

The effect of ciprofloxacin, lomefloxacin, fleroxacin and ofloxacin on the intracellular killing of Staphylococcus aureus in human neutrophil granulocytes was studied. Each drug was tested in concentrations of 0.25, 1, 4, 16 and 64 times the MIC and the intracellular killing was measured for up to 5 h of incubation. All four quinolones increased the intracellular killing in a concentration- and time-dependent manner. When compared at concentrations of 4 x MIC, ofloxacin increased the killing significantly more than the other quinolones. All four quinolones increased the killing significantly more than the beta-lactam dicloxacillin. All five antibiotics increased the killing significantly relative to the control without antibiotics. None of the antibiotics affected the viability of the granulocytes or their ability to generate superoxide anion. In conclusion, the quinolones increased the intracellular killing of S. aureus in neutrophil granulocytes.

Citations

Oct 3, 2002·Biochemical and Biophysical Research Communications·M C Becerra, I Albesa
Jun 13, 1998·International Journal of Antimicrobial Agents·M T Labro
Sep 21, 2002·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·L A BaşZ G Değim
Sep 15, 2001·Antimicrobial Agents and Chemotherapy·H AbdelghaffarM T Labro
Feb 6, 2004·Journal of Bacteriology·S N A QaziP J Hill
Jan 4, 2007·Analytical and Bioanalytical Chemistry·Patrícia NevesPaula Gameiro
Jul 29, 2010·Obstetrics and Gynecology·David E Soper
Jun 16, 2007·Wiener klinische Wochenschrift·Christina KratzerApostolos Georgopoulos
Jan 24, 2004·The Tohoku Journal of Experimental Medicine·Serkan OncuHaluk Eraksoy
Nov 7, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Radek SlehaJaroslava Mazurova
Jan 14, 2004·Drugs·Xian-Zhi Li, Hiroshi Nikaido
Sep 16, 2005·Journal of Computer Assisted Tomography·Fumito OkadaHiromu Mori
Apr 2, 2010·Pharmacy World & Science : PWS·Franky BuyleHugo Robays
Apr 30, 2002·Current Opinion in Infectious Diseases·M R Hammerschlag
Apr 20, 2001·Paediatric Drugs·S Esposito, N Principi
Feb 8, 2013·Journal of Clinical Gastroenterology·Nimish Vakil, Dino Vaira
Feb 19, 2010·Nursing·Kim Delahanty, Frank Myers
Jul 20, 2007·Internal Medicine·Takahito NeiShoji Kudoh
Nov 23, 2006·Biochimica Et Biophysica Acta·Mahesh SubramanianSubrata Chattopadhyay
Apr 28, 2004·Free Radical Biology & Medicine·Masayuki NiwaSadaki Fujimoto
Dec 20, 2005·Pulmonary Pharmacology & Therapeutics·Maria Gabriella Matera
Mar 8, 2013·PloS One·Constantin N TakacsChristine Jacobs-Wagner
Jan 5, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Elvira Garza-González, Michael Joseph Dowzicky
Aug 17, 2004·Infectious Disease Clinics of North America·Maria Joyce, Christopher W Woods

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.